COPD clinical trials in California
26 studies for COPD are looking for participants at sites in California.
Cities in California
- Los Angeles9 studies
- Newport Beach8 studies
- San Francisco5 studies
- Mountain View3 studies
- Santa Clarita3 studies
- Buena Park3 studies
- San Diego3 studies
- Long Beach3 studies
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- NewportNativeMD, Inc., Newport Beach
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- IMAX Clinical Trials- Site Number : 8400109, La Palma
- Long Beach Research Institute- Site Number : 8400027, Long Beach
- Downtown L.A. Research Center- Site Number : 8400009, Los Angeles
- and 3 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Newport Native MD- Site Number : 8403003, Newport Beach
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 21, 2026 · NCT07793409A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Los Angeles
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07646587Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Inglewood Clinical- Site Number : 8400074, Inglewood
- Ark Clinical Research- Site Number : 8400113, Long Beach
- Alliance Clinical - West Hills- Site Number : 8400067, Los Angeles
- and 1 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Los Angeles
- Research Site, Newport Beach
- Research Site, Norco
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Los Angeles
- Research Site, Palo Alto
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Garden Grove
- Research Site, Newport Beach
- Research Site, Torrance
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- Stanford Center for Excellence in Pulmonary Biology, Palo Alto
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- IMAX Clinical Trials, La Palma
- NewportNativeMD, Inc., Newport Beach
- California Medical Research Associates, Northridge
- and 1 more
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Castroville
- Research Site, Garden Grove
- Research Site, Inglewood
- and 12 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 100, Los Angelas
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- California Medical Research Associates Inc., Northridge
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 7, 2026 · NCT07684820STRIVE Post-Market Registry Study
- El Camino, Taft Center for Clinical Research, Mountain View
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of California, Los Angeles, Los Angeles
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Jul 31, 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Newport Beach
RecruitingPhase 3
Ages 40 to 75 · All sexes · Updated Jul 28, 2026 · NCT07177339Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
- San Francisco VA Medical Center, San Francisco
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Jun 4, 2026 · NCT04722835The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- UCSD Sleep Research, La Jolla
RecruitingPhase 2
Ages 40 to 79 · All sexes · Updated Jun 3, 2026 · NCT05237505SPIROMICS Study of Early COPD Progression (SOURCE)
- University of California Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Jun 3, 2026 · NCT05033990A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- University of California, San Francisco, San Francisco
Recruiting
Ages 22 and older · All sexes · Updated Jun 3, 2026 · NCT07119229Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of California at Davis, Sacramento
Recruiting
Ages 40 to 84 · All sexes · Updated Apr 24, 2026 · NCT06891755PiMZ Longitudinal Cohort (PiMZ Logic)
- University of California- Los Angeles, Los Angeles
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT06505603Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- Zuckerberg San Francisco General (ZSFG) Hospital, San Francisco
- Maxine Hall Health Center (MHHC), San Francisco
- Southeast Health Center (SEHC), San Francisco
Recruiting
Ages 40 to 90 · All sexes · Updated Dec 1, 2025 · NCT05572632Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Science 37, Los Angeles
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
- Arthur F Gelb MD, Lakewood
- Arthur F Gelb MD, Lakewood
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Oct 27, 2023 · NCT03263130From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.